Research Compound Profile

Tirzepatide: Research Profile (November 2026)

Tirzepatide is a 39-residue synthetic peptide based on the GIP sequence that activates both the GIP and GLP-1 receptors.

For laboratory research and educational purposes only. This profile summarizes published preclinical and analytical literature and is not medical advice or dosing guidance.

Research-Grade Tirzepatide

Supplied as Tirzepatide 10mg with a batch-specific HPLC and mass spectrometry COA — verify any batch.

Further Reading

Other Compound Profiles